NO166284C - Fremgangsmaate for fremstilling av en stoffblanding som ereffektiv til lokalisering og/eller oedeleggelse av tumorer. - Google Patents

Fremgangsmaate for fremstilling av en stoffblanding som ereffektiv til lokalisering og/eller oedeleggelse av tumorer.

Info

Publication number
NO166284C
NO166284C NO84842089A NO842089A NO166284C NO 166284 C NO166284 C NO 166284C NO 84842089 A NO84842089 A NO 84842089A NO 842089 A NO842089 A NO 842089A NO 166284 C NO166284 C NO 166284C
Authority
NO
Norway
Prior art keywords
tumors
molecular weight
localization
substance
destruction
Prior art date
Application number
NO84842089A
Other languages
English (en)
Norwegian (no)
Other versions
NO166284B (no
NO842089L (no
Inventor
Kenneth R Weishaupt
Thomas J Dougherty
William R Potter
Original Assignee
Photofrin Medical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Photofrin Medical Inc filed Critical Photofrin Medical Inc
Publication of NO842089L publication Critical patent/NO842089L/no
Publication of NO166284B publication Critical patent/NO166284B/no
Publication of NO166284C publication Critical patent/NO166284C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
    • A61B5/0075—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence by spectroscopy, i.e. measuring spectra, e.g. Raman spectroscopy, infrared absorption spectroscopy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
    • A61B5/0082—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence adapted for particular medical purposes
    • A61B5/0084—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence adapted for particular medical purposes for introduction into the body, e.g. by catheters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0601—Apparatus for use inside the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0613—Apparatus adapted for a specific treatment
    • A61N5/062—Photodynamic therapy, i.e. excitation of an agent

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Radiation-Therapy Devices (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
NO84842089A 1982-09-27 1984-05-25 Fremgangsmaate for fremstilling av en stoffblanding som ereffektiv til lokalisering og/eller oedeleggelse av tumorer. NO166284C (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US42464782A 1982-09-27 1982-09-27
US48134583A 1983-04-01 1983-04-01
PCT/US1983/001379 WO1984001382A1 (en) 1982-09-27 1983-09-09 Purified hematoporphyrin derivative for diagnosis and treatment of tumors, and method

Publications (3)

Publication Number Publication Date
NO842089L NO842089L (no) 1984-05-25
NO166284B NO166284B (no) 1991-03-18
NO166284C true NO166284C (no) 1991-06-26

Family

ID=27026406

Family Applications (1)

Application Number Title Priority Date Filing Date
NO84842089A NO166284C (no) 1982-09-27 1984-05-25 Fremgangsmaate for fremstilling av en stoffblanding som ereffektiv til lokalisering og/eller oedeleggelse av tumorer.

Country Status (10)

Country Link
EP (1) EP0120054B1 (de)
JP (1) JPS60500132A (de)
AT (1) ATE53204T1 (de)
AU (1) AU581840B2 (de)
CA (1) CA1271746A (de)
DE (1) DE3381616D1 (de)
DK (1) DK172284B1 (de)
NL (1) NL940021I2 (de)
NO (1) NO166284C (de)
WO (1) WO1984001382A1 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4649151A (en) * 1982-09-27 1987-03-10 Health Research, Inc. Drugs comprising porphyrins
US4693885A (en) * 1984-07-18 1987-09-15 Nippon Petrochemicals Co., Ltd. Tetrapyrrole therapeutic agents
US4675338A (en) * 1984-07-18 1987-06-23 Nippon Petrochemicals Co., Ltd. Tetrapyrrole therapeutic agents
US5104637A (en) * 1985-02-06 1992-04-14 University Of Cincinnati Radio labeled dihematophorphyrin ether and its use in detecting and treating neoplastic tissue
AU589957B2 (en) * 1985-04-30 1989-10-26 Nippon Petrochemicals Company Limited New tetrapyrrole therapeutic agents
US4656186A (en) 1985-04-30 1987-04-07 Nippon Petrochemicals Co., Ltd. Tetrapyrrole therapeutic agents
US4977177A (en) * 1985-04-30 1990-12-11 Nippon Petrochemicals Company, Ltd. Tetrapyrrole polyaminomonocarboxylic acid therapeutic agents
US5066274A (en) * 1985-04-30 1991-11-19 Nippon Petrochemicals Company, Ltd. Tetrapyrrole therapeutic agents
GB8522670D0 (en) * 1985-09-13 1985-10-16 Efamol Ltd Drug treatments
DE3687399T2 (de) * 1985-10-23 1993-04-29 Nihon Mediphysics Co Ltd Porphyrinderivate, ihre herstellung und verwendung.
US5534506A (en) * 1986-01-02 1996-07-09 University Of Toledo Use of purpurins, chlorins and purpurin- and chlorin-containing compositions
US5216012A (en) * 1986-01-02 1993-06-01 University Of Toledo Production and use of purpurins, chlorins and purpurin- and chlorin-containing compositions
US5051415A (en) * 1986-01-02 1991-09-24 The University Of Toledo Production and use of purpurins, chlorins and purpurin- and chlorin-containing compositions
ATE87826T1 (de) * 1986-01-02 1993-04-15 Univ Toledo Herstellung und verwendung von purpurinen, chlorinen und purpurin und chlorin enthaltenden zubereitungen.
US4882234A (en) * 1986-11-12 1989-11-21 Healux, Inc. Storage-stable porphin compositions and a method for their manufacture
US5171749A (en) * 1987-01-20 1992-12-15 University Of British Columbia Wavelength-specific cytotoxic agents
US5283255A (en) * 1987-01-20 1994-02-01 The University Of British Columbia Wavelength-specific cytotoxic agents
US4920143A (en) * 1987-04-23 1990-04-24 University Of British Columbia Hydro-monobenzoporphyrin wavelength-specific cytotoxic agents
US4925736A (en) * 1988-07-06 1990-05-15 Long Island Jewish Medical Center Topical hematoporphyrin
USRE39094E1 (en) 1988-07-20 2006-05-09 Health Research, Inc. Pyropheophorbides and their use in photodynamic therapy
USRE38994E1 (en) 1988-07-20 2006-02-28 Health Research, Inc. Pyropheophorbides conjugates and their use in photodynamic therapy
GB2254417A (en) * 1991-04-05 1992-10-07 Bijan Jouza Photodynamic laser detection for cancer diagnosis
NL9200143A (nl) * 1992-01-27 1993-08-16 Seehof Lab F & E Ges Werkwijze voor de bereiding van een actief middel te gebruiken voor de fotodynamische therapie en voor het vaststellen van een diagnose, therapeutisch middel en diagnosticum dat het actief middel bevat en farmaceutische samenstelling.
RU2128993C1 (ru) * 1996-03-27 1999-04-20 Московская государственная академия тонкой химической технологии им.М.В.Ломоносова Фармакологическое средство фотогем для фотодинамической терапии рака
US5948061A (en) 1996-10-29 1999-09-07 Double Click, Inc. Method of delivery, targeting, and measuring advertising over networks
AU8072798A (en) 1997-06-16 1999-01-04 Doubleclick Inc. Method and apparatus for automatic placement of advertising
WO2000008802A2 (en) 1998-08-03 2000-02-17 Doubleclick Inc. Network for distribution of re-targeted advertising
US7897140B2 (en) 1999-12-23 2011-03-01 Health Research, Inc. Multi DTPA conjugated tetrapyrollic compounds for phototherapeutic contrast agents
US6624187B1 (en) 2000-06-12 2003-09-23 Health Research, Inc. Long wave length absorbing bacteriochlorin alkyl ether analogs
AU2003248747A1 (en) 2002-06-27 2004-01-19 Health Research, Inc. Fluorinated chlorin and bacteriochlorin photosensitizers for photodynamic therapy
WO2004005289A2 (en) 2002-07-02 2004-01-15 Health Research, Inc. Efficient synthesis of pyropheophorbide a and its derivatives

Also Published As

Publication number Publication date
DK261384A (da) 1984-05-25
AU581840B2 (en) 1989-03-09
NO166284B (no) 1991-03-18
JPS60500132A (ja) 1985-01-31
NO842089L (no) 1984-05-25
EP0120054B1 (de) 1990-05-30
DK261384D0 (da) 1984-05-25
WO1984001382A1 (en) 1984-04-12
NL940021I1 (nl) 1997-03-03
EP0120054A4 (de) 1985-04-11
AU2032283A (en) 1984-04-24
NL940021I2 (nl) 1997-05-01
EP0120054A1 (de) 1984-10-03
ATE53204T1 (de) 1990-06-15
DK172284B1 (da) 1998-02-23
DE3381616D1 (de) 1990-07-05
CA1271746A (en) 1990-07-17

Similar Documents

Publication Publication Date Title
DK261384D0 (da) Renset hematoporphyrinderivat til diagnose og behandling af tumorer
EP0127471B1 (de) Phosphorsäurediester, Salze davon, diese enthaltende Zusammensetzungen und Verfahren zur Herstellung solcher Diester und Salze
PT88944A (pt) Processo para a preparacao de novos derivados de benzociclohepteno e de composicoes farmaceuticas que os contem
Schilling et al. Isolation, Structure and Synthesis of a Lathyrus Factor From L. Odoratus1, 2
ATE25246T1 (de) Triphenylimidazolyloxyalkansaeuren und ihre derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate.
CH676715A5 (de)
ZA832044B (en) Imidazolyphenyl-tetrahydropyridazines,processes for their preparation and pharmaceutical preparation containing them
PT76279B (en) Process for the preparation of novel crystal modifications of (+)-catechin
AU611113B2 (en) Basically substituted phenylacetonitriles, their preparation and drugs containing these compounds
DE2730549A1 (de) Peptidderivate und deren herstellung
ATE4169T1 (de) Antacidum auf der basis von magnesium-aluminium- hydroxyd und seine herstellung.
Slocum et al. The preparation of several N-Substituted and N, N-Disubstituted ferrocenesulfonamides
PT80791A (fr) Procede de preparation de nouvelles phenyl-naphtiridines utiles notamment comme medicaments anti-ulceres
US3838150A (en) Disaccharide polysulfate ester hydroxyaluminum allantoinate-aluminum complex and process for preparing same
EP0207483A3 (en) Benzimidazoles, process for their preparation, medicaments containing them and intermediates
JPS6136227A (ja) アンジオテンシン転換酵素阻害剤
EP0224844A3 (en) Process for producing peptides by the use of perchlorates
KR960017680A (ko) 포스포노술포네이트 스쿠알렌 합성 효소 억제제 염 및 그의 제조 방법
WO1986000621A1 (fr) Hexapeptide
SU814860A1 (ru) Способ получени модифицированногодиСпЕРСНОгО КРЕМНЕзЕМА
JPS5795918A (en) Purification of immunoglobulin
Brookes Studies on the incorporation of an unnatural amino acid, p-di-(2-hydroxy [14C2] ethyl) amino-L-phenylalanine, into proteins
RU2148583C1 (ru) 3-О-2-ДЕЗОКСИ-α-D-ГАЛАКТО- ИЛИ α-L-РАМНОПИРАНОЗИД МЕТИЛОВОГО ЭФИРА ГЛИЦИРРЕТОВОЙ КИСЛОТЫ, ПРОЯВЛЯЮЩИЙ ПРОТИВОЯЗВЕННУЮ АКТИВНОСТЬ И СТИМУЛИРУЮЩИЙ РЕПАРАТИВНУЮ РЕГЕНЕРАЦИЮ КОЖИ
SU891702A1 (ru) Способ получени полимеров
SU469702A1 (ru) Способ получени производных 4-нитро-5-арил-1,2,3-триазола

Legal Events

Date Code Title Description
MK1K Patent expired

Free format text: EXPIRED IN SEPTEMBER 2003